Meeting
2014 ASCO Annual Meeting
BRCAPRO 6.0 model validation in male patients presenting for BRCA testing.
Authors
Zahi Ibrahim Mitri
The University of Texas MD Anderson Cancer Center, Houston, TX
Zahi Ibrahim Mitri , Michelle Jackson , Carolyn Garby , Sharon Hermes Giordano , Gabriel N. Hortobagyi , Claire Singletary , S. Shahrukh Hashmi , Banu Arun , Jennifer Keating Litton
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Cancer Prevention/Epidemiology
Track
Cancer Prevention/Epidemiology
Sub Track
Cancer Genetics
Citation
J Clin Oncol 32:5s, 2014 (suppl; abstr 1559)
DOI
10.1200/jco.2014.32.15_suppl.1559
Abstract #
1559
Poster Bd #
341
Abstract Disclosures
Similar Posters
Poster
2018 ASCO Annual Meeting
The association of BRCA1 and BRCA2 mutations on prostate cancer risk, frequency, and mortality: Systematic review and meta-analysis.
First Author: Mok Oh
Poster
2021 ASCO Annual Meeting
Risk-reducing salpingo-oophorectomy and breast cancer incidence among BRCA-mutation carriers.
First Author: Tamar Perri
Poster
2020 Genitourinary Cancers Symposium
Circulating tumor (ct) DNA-based comprehensive genomic profiling to identify microsatellite instability (MSI) and defective DNA damage repair (DDR) in prostate cancer (PCa) patients.
First Author: Leylah M. Drusbosky
Poster
2019 Genitourinary Cancers Symposium
Are prostate cancer patients with BRCA1 and BRCA2 mutations safe for active surveillance?
First Author: Marc Dall'era